Moshe Yanai

Portfolio · 4

Quris-AI

AI-based Drug Development Platform

1 round $9.0M committed Latest: 2021-10

INFINIDAT

Enterprise Data and Cloud Storage Solutions

2 rounds $80.0M committed Latest: 2020-06

Sight Diagnostics

Advanced Blood Diagnostics Platform

2 rounds $9.2M committed Latest: 2014-04

Axxana

Data Replication and Recovery Solutions

1 round $20.0M committed Latest: 2009-11

Investment activity

2 portfolio exits on record.

Q&A

What are some of Moshe Yanai's notable portfolio companies?

Moshe Yanai's portfolio includes INFINIDAT, an enterprise data and cloud storage solutions provider, and Quris-AI, an AI-based drug development platform.

Which of Moshe Yanai's portfolio companies have had exits?

Moshe Yanai has seen exits from INFINIDAT, which was acquired by Lenovo in January 2025, and Axxana, acquired by INFINIDAT in January 2018.

What is Moshe Yanai's investment focus by sector?

Moshe Yanai shows a concentration in Health Tech & Life Sciences, with two portfolio companies in this sector, and Business Software, with one portfolio company.

Can you describe a recent exit for Moshe Yanai?

In January 2025, INFINIDAT, a company in Moshe Yanai's portfolio, was acquired by Lenovo.

What is Moshe Yanai's activity in the Health Tech & Life Sciences sector?

Moshe Yanai has invested in two companies within the Health Tech & Life Sciences sector, including Quris-AI, an AI-based drug development platform, and Sight Diagnostics, an advanced blood diagnostics platform.

What was a significant acquisition involving one of Moshe Yanai's portfolio companies in 2018?

In January 2018, Axxana, a data replication and recovery solutions provider in Moshe Yanai's portfolio, was acquired by INFINIDAT.